ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract #1041607: Effects of Prior Injectable Somatostatin Receptor Ligand Type and Dose in Patients With Acromegaly Receiving Oral Octreotide Capsules in the Phase 3 MPOWERED Trial
Endocrine Practice
◽
10.1016/j.eprac.2021.04.745
◽
2021
◽
Vol 27
(6)
◽
pp. S131
Author(s):
Murray B. Gordon
◽
Maria Fleseriu
◽
Nienke Biermasz
◽
Alexander Dreval
◽
Yulia G. Pokramovich
◽
...
Keyword(s):
Somatostatin Receptor
◽
Phase 3
◽
Receptor Ligand
◽
Ligand Type
◽
Somatostatin Receptor Ligand
Download Full-text
Related Documents
Cited By
References
Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study
Endocrine Abstracts
◽
10.1530/endoabs.70.aep668
◽
2020
◽
Author(s):
Lisa Nachtigall
◽
Susan Samson
◽
Maria Fleseriu
◽
Marek Bolanowski
◽
Molitch Mark E
◽
...
Keyword(s):
Somatostatin Receptor
◽
Adult Patients
◽
Phase 3
◽
Double Blind
◽
Receptor Ligand
◽
Double Blind Placebo
◽
Long Acting
◽
Somatostatin Receptor Ligand
Download Full-text
In Vivo Cellular Distribution and Endocytosis of the Somatostatin Receptor-Ligand Complex
Acta Oncologica
◽
10.1080/028418699431483
◽
1999
◽
Vol 38
(3)
◽
pp. 383-387
◽
Cited By ~ 5
Author(s):
Agneta Lukinius, Ulf Öhrvall, Jan-E
Keyword(s):
Somatostatin Receptor
◽
Cellular Distribution
◽
Ligand Complex
◽
Receptor Ligand
◽
Somatostatin Receptor Ligand
Download Full-text
Uptake kinetics of the somatostatin receptor ligand [ 86 Y]DOTA- d Phe 1 -Tyr 3 -octreotide ([ 86 Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90 Y-labelled analogue
European Journal of Nuclear Medicine and Molecular Imaging
◽
10.1007/s002590050398
◽
1999
◽
Vol 26
(4)
◽
pp. 358-366
◽
Cited By ~ 65
Author(s):
Frank Rösch
◽
Hans Herzog
◽
Barbara Stolz
◽
Jörg Brockmann
◽
Martin Köhle
◽
...
Keyword(s):
Positron Emission Tomography
◽
Somatostatin Receptor
◽
Uptake Kinetics
◽
Emission Tomography
◽
Radiation Doses
◽
Receptor Ligand
◽
Positron Emission
◽
Somatostatin Receptor Ligand
◽
Kinetics Of
Download Full-text
Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
The Journal of Clinical Endocrinology & Metabolism
◽
10.1210/jc.2013-3757
◽
2014
◽
Vol 99
(5)
◽
pp. 1825-1833
◽
Cited By ~ 79
Author(s):
John D. Carmichael
◽
Vivien S. Bonert
◽
Miriam Nuño
◽
Diana Ly
◽
Shlomo Melmed
Keyword(s):
Clinical Trial
◽
Meta Analysis
◽
Somatostatin Receptor
◽
Trial Methodology
◽
Receptor Ligand
◽
Clinical Trial Methodology
◽
Somatostatin Receptor Ligand
Download Full-text
Faculty Opinions recommendation of A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.723730401.793511695
◽
2015
◽
Author(s):
Niki Karavitaki
◽
Georgia Ntali
Keyword(s):
Somatostatin Receptor
◽
Receptor Ligand
◽
Sleep Parameters
◽
Somatostatin Receptor Ligand
◽
Unselected Cohort
◽
Comprehensive Study
Download Full-text
Identification of a dose range for once daily oral paltusotine in patients with acromegaly that maintains IGF-1 levels when switching from long-acting somatostatin receptor ligand therapy
Endocrine Abstracts
◽
10.1530/endoabs.73.oc15.4
◽
2021
◽
Author(s):
Murray B. Gordon
◽
Monica Gadelha
◽
Miklos Toth
◽
Mirjana Doknic
◽
Emese Mezosi
◽
...
Keyword(s):
Dose Range
◽
Somatostatin Receptor
◽
Receptor Ligand
◽
Once Daily
◽
Long Acting
◽
Somatostatin Receptor Ligand
Download Full-text
Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors
Drugs of Today
◽
10.1358/dot.2013.49.2.1915142
◽
2013
◽
Vol 49
(2)
◽
pp. 89
◽
Cited By ~ 17
Author(s):
R.A. Feelders
◽
W.W. de Herder
◽
S.J. Neggers
◽
A.J. van der Lely
◽
L.J. Hofland
Keyword(s):
Neuroendocrine Tumors
◽
Somatostatin Receptor
◽
Receptor Ligand
◽
Potential Efficacy
◽
Somatostatin Receptor Ligand
Download Full-text
Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK
Medical Devices Evidence and Research
◽
10.2147/mder.s30913
◽
2012
◽
pp. 39
◽
Cited By ~ 2
Author(s):
Hannah Kurth
◽
Marty
◽
Roze
Keyword(s):
Health Economic
◽
Decision Tree
◽
Somatostatin Receptor
◽
Decision Tree Model
◽
Tree Model
◽
Receptor Ligand
◽
Long Acting
◽
The Uk
◽
Somatostatin Receptor Ligand
◽
Economic Comparison
Download Full-text
Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer
Journal of the ASEAN Federation of Endocrine Societies
◽
10.15605/jafes.03.02.12
◽
2017
◽
Vol 32
(2)
◽
pp. 169-172
Author(s):
Shalini Sree Dharan
◽
◽
Nor Azmi Kamaruddin
Keyword(s):
Thyroid Cancer
◽
Medical Therapy
◽
Somatostatin Receptor
◽
Receptor Ligand
◽
Somatostatin Receptor Ligand
Download Full-text
PET/CT Imaging of Unstable Carotid Plaque with68Ga-Labeled Somatostatin Receptor Ligand
Journal of Nuclear Medicine
◽
10.2967/jnumed.116.181438
◽
2016
◽
Vol 58
(5)
◽
pp. 774-780
◽
Cited By ~ 13
Author(s):
Ming Young Simon Wan
◽
Raymond Endozo
◽
Sofia Michopoulou
◽
Robert Shortman
◽
Manuel Rodriguez-Justo
◽
...
Keyword(s):
Carotid Plaque
◽
Somatostatin Receptor
◽
Ct Imaging
◽
Receptor Ligand
◽
Pet Ct
◽
Somatostatin Receptor Ligand
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close